About Event
Join the 5th Glioblastoma Drug Development Summit
No matter what stage you’re at, this is your go-to event for driving forward GBM drug development.
With the continued high level of unmet need for this devastating disease, the 5th Glioblastoma Drug Development Summit returns as a much-needed platform to put the spotlight on novel scientific breakthroughs and valuable insights to bring that much needed cure one step closer.
This unparalleled event brings together key opinion leaders from pharmaceutical giants and innovative biotechs, along with a hand-picked group of leading academics, neurosurgeons and clinical trial experts, with a clear unwavering focus on bringing much-needed glioblastoma drugs to market.
Reunite with your community to:
Discover novel drug targets and mechanisms of action to spark ideas for innovative new treatments and combinatorial approaches for this complex cancer
Gain insights into the very latest GBM-specific clinical trial rationale including brand new & improved response criteria and clinical endpoints, backed up by recent success stories with implementable tips for success.
Navigate the recurring barriers to success in GBM such as tumor heterogeneity and the microenvironment with data-driven actionable insights from established experts
Connect with the passionate GBM community to share ideas and form crucial partnerships with over 4 hours of dedicated networking sessions and a poster presentation slot
Tackle the renowned issue of risk-aversity in GBM funding with a powerful investor panel discussion producing practical takeaways on how to overcome this frustrating hurdle
Who will you meet?
An audience of key opinion leaders in the glioblastoma space, consisting of C-level executives, directors, neuro-oncologists, clinicians, and scientists covering discovery through to translation and clinical development.